Duncan McKechnie

Questioner
DISC Type : c

EVP, Chief Commercial Officer at Vertex Pharmaceuticals

Cambridge, Massachusetts, United States

Overview

Duncan McKechnie is the Executive Vice President and Chief Commercial Officer at Vertex Pharmaceuticals, leveraging over 25 years of biopharmaceutical experience. His expertise spans brand positioning, product launches, and sales management, with previous leadership roles at Novartis. He holds a degree in Business Studies from the University of Plymouth.

He is currently spearheading the launch of a potentially transformative non-opioid pain medicine, building the commercial team and strategy from the ground up.

Personality Overview

Cautious & Analytical

Value Seeker

Systematic

They are more likely than others to negotiate on pricing and terms.  They prefer to fully evaluate every situation. While they don't hesitate to ask questions, they are generally risk-averse and tend to be late adopters.

Topics They Care About

Pain Management Innovation
He is leading the high-profile commercial launch of a novel, non-opioid pain medicine, aiming to address a significant unmet need in the market.
Commercial Launch Strategy
Actively building a new multi-functional field team and marketing leadership to support a major upcoming product launch in the pain therapeutic area.
Hospital Sales Leadership
He has publicly emphasized the need for leaders with significant hospital and Integrated Delivery Network (IDN) experience for Vertex's go-to-market efforts.

Media Appearances

Leadership | Duncan McKechnie - Vertex Pharmaceuticals. Featured in Vertex.com

See Now

Duncan J McKechnie, Vertex Pharmaceuticals Inc - Bloomberg.com. Featured in Bloomberg

See Now

Work History

7-2025
EVP, Chief Commercial Officer at Vertex Pharmaceuticals
10-2018 - 7-2025
SVP North America Commercial Operations at Vertex Pharmaceuticals
6-2013 - 10-2018
VP Global Commercial Strategy at Vertex Pharmaceuticals
1-2013 - 6-2013
VP Respiratory Franchise at Novartis
4-2012 - 4-2013
VP & Head, Brand Maximization and Established Medicines at Novartis

Education

1986 - 1990
Business Studies from University of Plymouth
1981 - 1986
Education details unavailable from Oakham School, UK

More Information

Social Presence :

Prographics :

Exp : 17 Location : Cambridge, Massachusetts, United States Job Level : Leadership Designation : EVP, Chief Commercial Officer at Vertex Pharmaceuticals
URL has been copied!

Insights For Selling To Duncan

During A Call Or A Meeting

DO's

  • Emphasize on objective proof of ROI, help them do a thorough evaluation
  • Back up any claims with data and numbers
  • Emphasise more on facts and measurable benefits

DONT's

  • Don’t overhype the product/pitch, keep it measured
  • Don’t depend too much on anecdotal evidence, it reduces their confidence
  • Avoid rushing them, be polite and patient

When Cold Calling

When Writing An Email

While Negotiating & Closing

    The secret to closing fast with Duncan is

  • Confidence that the product provides ROI, effective pricing and process adherence matter the most to them.

  • Will you ever get a clear answer from Duncan

  • It doesn’t come naturally to them but they can say no if they are not convinced.

Insights For Deal Planning

    How fast (or slow) will Duncan move?

  • They can move at a reasonable pace while making their decisions if they have the necessary information.

  • Can Duncan take some risk or not?

  • If they believe that they have analyzed the situation well, they can take a little risk.

You And Duncan

Personality Compatibility


Other Vertex Pharmaceuticals Employees

Explore more public profiles from related professionals at the same organization.

More Profiles

Discover additional public profiles from our index.

Search more profiles

Looking for someone else? Search here for anyone.

Or visit Humantic AI to know more.